248 related articles for article (PubMed ID: 20381558)
21. [Telomere and telomerase in human cancer].
Hiyama K; Hiyama E; Ishioka S; Yamakido M
Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
[TBL] [Abstract][Full Text] [Related]
22. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Ward RJ; Autexier C
Mol Pharmacol; 2005 Sep; 68(3):779-86. PubMed ID: 15939802
[TBL] [Abstract][Full Text] [Related]
24. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
25. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
[TBL] [Abstract][Full Text] [Related]
26. Telomere maintenance as a target for drug discovery.
Sekaran V; Soares J; Jarstfer MB
J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
[TBL] [Abstract][Full Text] [Related]
27. Targeting human telomerase in cancer therapy.
Huard S; Autexier C
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
[TBL] [Abstract][Full Text] [Related]
28. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?
Kyo S; Inoue M
Oncogene; 2002 Jan; 21(4):688-97. PubMed ID: 11850797
[TBL] [Abstract][Full Text] [Related]
29. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibitors.
Rowley PT; Tabler M
Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
[TBL] [Abstract][Full Text] [Related]
31. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
[TBL] [Abstract][Full Text] [Related]
32. Telomerase inhibition as cancer therapy.
Saretzki G
Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
[TBL] [Abstract][Full Text] [Related]
33. Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length.
Nakai R; Ishida H; Asai A; Ogawa H; Yamamoto Y; Kawasaki H; Akinaga S; Mizukami T; Yamashita Y
Chem Biol; 2006 Feb; 13(2):183-90. PubMed ID: 16492566
[TBL] [Abstract][Full Text] [Related]
34. Telomerase regulation: a key to inhibition? (Review).
Gómez DL; Farina HG; Gómez DE
Int J Oncol; 2013 Nov; 43(5):1351-6. PubMed ID: 24042470
[TBL] [Abstract][Full Text] [Related]
35. Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies.
Folini M; Zaffaroni N
Curr Pharm Des; 2005; 11(9):1105-17. PubMed ID: 15853659
[TBL] [Abstract][Full Text] [Related]
36. Design of telomerase inhibitors for the treatment of cancer.
Cairns D; Anderson RJ; Perry PJ; Jenkins TC
Curr Pharm Des; 2002; 8(27):2491-504. PubMed ID: 12369943
[TBL] [Abstract][Full Text] [Related]
37. Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Dikmen ZG; Ozgurtas T; Gryaznov SM; Herbert BS
Biochim Biophys Acta; 2009 Apr; 1792(4):240-7. PubMed ID: 19419695
[TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibitors: a patent review (2010-2015).
Man RJ; Chen LW; Zhu HL
Expert Opin Ther Pat; 2016 Jun; 26(6):679-88. PubMed ID: 27104627
[TBL] [Abstract][Full Text] [Related]
39. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Colangelo D; Osella D
Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
[TBL] [Abstract][Full Text] [Related]
40. Telomerase inhibitors for the treatment of cancer: the current perspective.
Perry PJ; Arnold JR; Jenkins TC
Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
